{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T14:31:00Z","timestamp":1761489060566},"reference-count":39,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2013,1,4]],"date-time":"2013-01-04T00:00:00Z","timestamp":1357257600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0053353","type":"journal-article","created":{"date-parts":[[2013,1,4]],"date-time":"2013-01-04T22:06:58Z","timestamp":1357337218000},"page":"e53353","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":17,"title":["Differential Expression of Growth Factor Receptors and Membrane-Bound Tumor Markers for Imaging in Male and Female Breast Cancer"],"prefix":"10.1371","volume":"8","author":[{"given":"Jeroen F.","family":"Vermeulen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Kornegoor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elsken","family":"van der Wall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Petra","family":"van der Groep","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul J.","family":"van Diest","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2013,1,4]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"4381","DOI":"10.1200\/JCO.2011.36.8902","article-title":"Incidence and outcome of male breast cancer: an international population-based study","volume":"29","author":"H Miao","year":"2011","journal-title":"J Clin Oncol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1200\/JCO.2009.23.8162","article-title":"Male breast cancer: a population-based comparison with female breast cancer","volume":"28","author":"WF Anderson","year":"2010","journal-title":"J Clin Oncol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S0140-6736(06)68226-3","article-title":"Male breast cancer","volume":"367","author":"IS Fentiman","year":"2006","journal-title":"Lancet"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/cncr.20312","article-title":"Breast carcinoma in men: a population-based study","volume":"101","author":"SH Giordano","year":"2004","journal-title":"Cancer"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1007\/s10549-011-1856-9","article-title":"A comparative biomarker study of 514 matched cases of male and female breast cancer reveals gender-specific biological differences","volume":"133","author":"AM Shaaban","year":"2012","journal-title":"Breast Cancer Res Treat"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"R28","DOI":"10.1186\/bcr2258","article-title":"Immunohistochemical characterization of subtypes of male breast carcinoma","volume":"11","author":"Y Ge","year":"2009","journal-title":"Breast Cancer Res"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/modpathol.2011.174","article-title":"Molecular subtyping of male breast cancer by immunohistochemistry","volume":"25","author":"R Kornegoor","year":"2012","journal-title":"Mod Pathol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/j.1365-2559.2006.02519.x","article-title":"Cytokeratin profiles of male breast cancers","volume":"49","author":"V Ciocca","year":"2006","journal-title":"Histopathology"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1046\/j.1524-4741.1998.440261.x","article-title":"Prognostic indicators in male breast carcinoma","volume":"4","author":"J Moore","year":"1998","journal-title":"Breast J"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1186\/1471-2407-11-335","article-title":"Matched-pair analysis of patients with female and male breast cancer: a comparative analysis","volume":"11","author":"R Foerster","year":"2011","journal-title":"BMC Cancer"},{"key":"ref11","first-page":"2335","article-title":"Male breast cancer: pathological and immunohistochemical features","volume":"17","author":"PC Willsher","year":"1997","journal-title":"Anticancer Res"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/path.1711660104","article-title":"Oestrogen receptor and epidermal growth factor receptor expression in male breast carcinoma","volume":"166","author":"SB Fox","year":"1992","journal-title":"J Pathol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1097\/CAD.0b013e328345ffa4","article-title":"Combining molecular targeted therapies: clinical experience","volume":"22","author":"X Pivot","year":"2011","journal-title":"Anticancer Drugs"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.breast.2011.06.009","article-title":"Trastuzumab combined to neoadjuvant chemotherapy in patients with HER2-positive breast cancer: a systematic review and meta-analysis","volume":"20","author":"A Valachis","year":"2011","journal-title":"Breast"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1517\/14712598.2011.582464","article-title":"Cetuximab in the treatment of patients with colorectal cancer","volume":"11","author":"CR Garrett","year":"2011","journal-title":"Expert Opin Biol Ther"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.2165\/11592540-000000000-00000","article-title":"Management of recurrent head and neck cancer: recent progress and future directions","volume":"71","author":"BE Brockstein","year":"2011","journal-title":"Drugs"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.2967\/jnumed.107.042234","article-title":"Dual-labeled trastuzumab-based imaging agent for the detection of human epidermal growth factor receptor 2 overexpression in breast cancer","volume":"48","author":"L Sampath","year":"2007","journal-title":"J Nucl Med"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"3840","DOI":"10.1158\/1078-0432.CCR-07-4076","article-title":"Affibody molecules for in vivo characterization of HER2-positive tumors by near-infrared imaging","volume":"14","author":"SB Lee","year":"2008","journal-title":"Clin Cancer Res"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1148\/radiol.2482071496","article-title":"Human breast cancer tumor models: molecular imaging of drug susceptibility and dosing during HER2\/neu-targeted therapy","volume":"248","author":"MS Gee","year":"2008","journal-title":"Radiology"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1245\/s10434-009-0609-z","article-title":"Obtaining adequate surgical margins in breast-conserving therapy for patients with early-stage breast cancer: current modalities and future directions","volume":"16","author":"RG Pleijhuis","year":"2009","journal-title":"Ann Surg Oncol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ejso.2010.10.006","article-title":"Near-infrared fluorescence (NIRF) imaging in breast-conserving surgery: assessing intraoperative techniques in tissue-simulating breast phantoms","volume":"37","author":"RG Pleijhuis","year":"2011","journal-title":"Eur J Surg Oncol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s10549-010-0760-z","article-title":"ICG fluorescence-guided sentinel node biopsy for axillary nodal staging in breast cancer","volume":"121","author":"C Hirche","year":"2010","journal-title":"Breast Cancer Res Treat"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.ygyno.2010.10.009","article-title":"Intraoperative near-infrared fluorescence imaging for sentinel lymph node detection in vulvar cancer: first clinical results","volume":"120","author":"LM Crane","year":"2011","journal-title":"Gynecol Oncol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1186\/1471-2407-12-240","article-title":"Immunophenotyping invasive breast cancer: paving the road for molecular imaging","volume":"12","author":"JF Vermeulen","year":"2012","journal-title":"BMC Cancer"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"e37864","DOI":"10.1371\/journal.pone.0037864","article-title":"Nuclear Kaiso expression is associated with high grade and triple-negative invasive breast cancer","volume":"7","author":"JF Vermeulen","year":"2012","journal-title":"PLoS One"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/j.1365-2559.1991.tb00229.x","article-title":"Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up","volume":"19","author":"CW Elston","year":"1991","journal-title":"Histopathology"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1136\/jcp.2005.032151","article-title":"Distinction between hereditary and sporadic breast cancer on the basis of clinicopathological data","volume":"59","author":"P van der Groep","year":"2006","journal-title":"J Clin Pathol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1097\/PAS.0b013e31824324e6","article-title":"The 3-layered ductal epithelium in gynecomastia","volume":"36","author":"R Kornegoor","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"ref29","unstructured":"CCMO website: Central Committee on Research involving Human Subjects (Centrale Commissie Mensgebonden Onderzoek) (text in Dutch). Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.ccmo-online.nl\/main.asp?pid=10&sid=30&ssid=51\" xlink:type=\"simple\">http:\/\/www.ccmo-online.nl\/main.asp?pid=10&amp;sid=30&amp;ssid=51<\/ext-link>. Accessed: 2012 Oct 1."},{"key":"ref30","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1136\/bmj.325.7365.648","article-title":"No consent should be needed for using leftover body material for scientific purposes. For","volume":"325","author":"PJ van Diest","year":"2002","journal-title":"BMJ"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1038\/modpathol.2012.101","article-title":"Fibrotic focus and hypoxia in male breast cancer","volume":"25","author":"R Kornegoor","year":"2012","journal-title":"Mod Pathol"},{"key":"ref32","first-page":"6429","article-title":"Insulin-like growth factor 1 receptors in human breast cancer and their relation to estradiol and progesterone receptors","volume":"48","author":"JP Peyrat","year":"1988","journal-title":"Cancer Res"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1093\/annonc\/mdf059","article-title":"Oestrogen\/insulin-like growth factor-I receptor interaction in early breast cancer: clinical implications","volume":"13","author":"BA Stoll","year":"2002","journal-title":"Ann Oncol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"e1000054","DOI":"10.1371\/journal.pgen.1000054","article-title":"Heterogeneity of breast cancer associations with five susceptibility loci by clinical and pathological characteristics","volume":"4","author":"M Garcia-Closas","year":"2008","journal-title":"PLoS Genet"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s10549-008-0087-1","article-title":"Expression profiling of familial breast cancers demonstrates higher expression of FGFR2 in BRCA2-associated tumors","volume":"117","author":"AL Bane","year":"2009","journal-title":"Breast Cancer Res Treat"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1093\/jnci\/djs172","article-title":"Breast cancer in men","volume":"104","author":"M Gethins","year":"2012","journal-title":"J Natl Cancer Inst"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1136\/jmg.2009.075176","article-title":"Risk of breast cancer in male BRCA2 carriers","volume":"47","author":"DG Evans","year":"2010","journal-title":"J Med Genet"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"3505","DOI":"10.1158\/0008-5472.CAN-07-6151","article-title":"Estrogen receptor regulation of carbonic anhydrase XII through a distal enhancer in breast cancer","volume":"68","author":"DH Barnett","year":"2008","journal-title":"Cancer Res"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/S0002-9440(10)64048-5","article-title":"Expression of the hypoxia-inducible and tumor-associated carbonic anhydrases in ductal carcinoma in situ of the breast","volume":"158","author":"CC Wykoff","year":"2001","journal-title":"Am J Pathol"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0053353","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T10:04:53Z","timestamp":1589018693000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0053353"}},"subtitle":[],"editor":[{"given":"Gayle E.","family":"Woloschak","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2013,1,4]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2013,1,4]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0053353","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,1,4]]}}}